NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Index- P/E- EPS (ttm)-0.82 Insider Own16.60% Shs Outstand84.62M Perf Week57.38%
Market Cap275.01M Forward P/E- EPS next Y-0.05 Insider Trans0.00% Shs Float70.57M Perf Month261.15%
Enterprise Value173.07M PEG- EPS next Q-0.03 Inst Own8.57% Short Float0.08% Perf Quarter273.21%
Income-83.61M P/S1.37 EPS this Y88.42% Inst Trans-36.28% Short Ratio0.08 Perf Half Y330.67%
Sales200.33M P/B1.33 EPS next Y56.12% ROA-20.75% Short Interest0.06M Perf YTD304.73%
Book/sh2.45 P/C1.80 EPS next 5Y74.12% ROE-28.91% 52W High3.60 -9.72% Perf Year229.34%
Cash/sh1.80 P/FCF- EPS past 3/5Y-302.21% - ROIC-31.63% 52W Low0.64 405.76% Perf 3Y293.98%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-8.08% 4.10% Gross Margin58.40% Volatility27.71% 17.90% Perf 5Y-74.85%
Dividend TTM0.00 (0.03%) EV/Sales0.86 EPS Y/Y TTM-4787.93% Oper. Margin-6.29% ATR (14)0.38 Perf 10Y-
Dividend Ex-DateApr 08, 2025 Quick Ratio2.45 Sales Y/Y TTM-4.68% Profit Margin-41.74% RSI (14)84.48 Recom3.00
Dividend Gr. 3/5Y- - Current Ratio2.75 EPS Q/Q-55.94% SMA2098.51% Beta1.73 Target Price0.80
Payout- Debt/Eq0.14 Sales Q/Q-7.74% SMA50178.94% Rel Volume9.03 Prev Close3.33
Employees1800 LT Debt/Eq0.08 EarningsMay 16 BMO SMA200245.75% Avg Volume708.28K Price3.25
IPOMay 02, 2019 Option/ShortYes / Yes EPS/Sales Surpr.-23.78% 2.39% Trades Volume6,397,598 Change-2.40%
Date Action Analyst Rating Change Price Target Change
Mar-22-23Upgrade Citigroup Neutral → Buy $0.80 → $3
Mar-23-21Reiterated Needham Buy $16 → $14
Apr-23-20Resumed Deutsche Bank Buy $16.20
Dec-05-19Initiated Jefferies Buy
May-28-19Initiated Needham Buy $16.50
May-28-19Initiated Deutsche Bank Buy
May-28-19Initiated Canaccord Genuity Buy
Jul-03-25 05:00AM
Jun-20-25 05:00AM
May-30-25 05:00AM
May-17-25 03:03AM
01:03AM
06:36AM Loading…
May-16-25 06:36AM
May-06-25 05:00AM
Apr-21-25 04:26PM
Apr-18-25 07:10AM
Apr-02-25 06:00AM
Mar-29-25 03:01PM
12:43AM
Mar-28-25 09:42AM
06:42AM
Mar-18-25 05:00AM
05:11AM Loading…
Mar-11-25 05:11AM
Feb-27-25 05:47AM
Nov-21-24 05:30AM
02:02AM
12:43AM
Nov-20-24 04:00AM
Nov-06-24 05:00AM
Aug-29-24 05:30AM
Aug-23-24 05:52AM
Aug-05-24 05:00AM
May-29-24 08:03AM
04:23AM
May-28-24 11:24AM
10:53AM
05:50AM
05:30AM Loading…
05:30AM
May-21-24 05:00AM
Apr-25-24 06:41AM
Mar-21-24 10:19AM
02:31AM
Mar-20-24 05:30AM
Mar-14-24 06:00AM
Mar-10-24 10:18AM
Jan-08-24 06:00AM
Jan-05-24 06:00AM
Dec-01-23 05:00AM
Nov-21-23 05:22PM
03:17PM
03:09AM
Nov-20-23 05:50AM
05:30AM
Nov-13-23 06:30AM
Nov-10-23 05:00AM
Oct-12-23 06:00AM
Aug-27-23 01:54PM
Aug-22-23 08:19AM
02:34AM
Aug-21-23 05:30AM
Aug-15-23 06:00AM
May-23-23 01:59AM
May-22-23 05:00AM
May-15-23 04:30PM
Apr-25-23 07:30AM
Mar-24-23 07:56AM
Mar-23-23 01:58AM
Mar-22-23 02:53AM
Mar-21-23 01:14PM
05:00AM
Mar-14-23 05:30AM
Jan-05-23 05:30AM
Jan-03-23 05:30AM
Dec-26-22 10:06PM
Nov-18-22 05:00AM
Nov-11-22 05:11AM
Oct-21-22 06:00AM
Aug-16-22 05:30AM
Aug-09-22 06:00AM
Jul-18-22 05:30AM
May-23-22 05:30AM
May-16-22 06:30AM
May-10-22 07:30AM
May-06-22 05:21AM
Mar-25-22 04:30AM
Mar-18-22 05:00AM
Dec-03-21 05:00AM
Nov-22-21 05:12PM
09:37AM
07:26AM
Nov-19-21 05:30AM
Nov-11-21 05:00AM
Sep-21-21 06:46AM
Sep-10-21 05:30AM
04:52AM
Aug-30-21 06:00AM
Aug-17-21 02:57PM
Jun-30-21 10:39AM
Jun-28-21 06:31AM
May-25-21 07:50AM
May-19-21 06:07AM
May-18-21 10:52AM
May-17-21 09:48AM
May-14-21 09:45AM
May-13-21 10:11PM
10:30AM
May-12-21 03:00PM
So-Young International, Inc. engages in the operation of a medical aesthetic service platform. It focuses on content and its distribution through major social media networks and targeted media platforms in China, social community characterized by signature user-generated content, and online reservation services for medical aesthetic treatment. The company was founded by Xing Jin and Tao Yu in March 2013 and is headquartered in Beijing, China.